Related Experiment Videos
Mutations in exon 3 of the PAH gene causing mild hyperphenylalaninemia
C Zekanowski1, M Nowacka, M Gizewska
1Department of Genetics, National Research Institute of Mother and Child, Warszawa, Poland. genmol@imid.med.pl
Abstract:
Phenylketonuria (PKU), an autosomal recessive disorder caused by a deficiency of hepatic phenylalanine hydroxylase (PAH), is clinically very heterogeneous. On molecular level more than 350 mutations in the PAH gene are known to date, which in different genotype combinations could account for biochemical and clinical variability. Mutations located in exon 3 coding for a part of the regulatory domain of the PAH enzyme cause classical PKU, mild PKU, and mild hyperphenylalaninemia (MHP). We describe the phenotypic effects of seven mutations in exon 3 of the PAH gene (R68G, R68S, R71H, S87R, P89S, I95F, and A104D). We propose that mutations located between amino acid positions 71 through 94 cause MHP.
Insights
Phenylketonuria (PKU) is a heterogeneous disorder linked to PAH gene mutations. Specific mutations in exon 3, particularly between amino acids 71-94, are associated with mild hyperphenylalaninemia (MHP).
Area of Science:
- Genetics
- Biochemistry
- Metabolic Disorders
Background:
- Phenylketonuria (PKU) is an autosomal recessive disorder resulting from phenylalanine hydroxylase (PAH) deficiency.
- Over 350 mutations in the PAH gene contribute to the clinical and biochemical variability observed in PKU patients.
- Mutations in exon 3 of the PAH gene are known to cause classical PKU, mild PKU, and mild hyperphenylalaninemia (MHP).
Purpose of the Study:
- To investigate the phenotypic effects of seven specific mutations within exon 3 of the PAH gene.
- To correlate specific mutations in exon 3 with different PKU phenotypes, including MHP.
- To identify a potential mutation hotspot within exon 3 associated with MHP.
Main Methods:
- Analysis of seven distinct mutations in exon 3 of the PAH gene: R68G, R68S, R71H, S87R, P89S, I95F, and A104D.
- Phenotypic characterization of patients carrying these mutations.
- Genotype-phenotype correlation to understand the impact of specific mutations on enzyme activity and clinical presentation.
Main Results:
- The study details the phenotypic outcomes associated with seven identified mutations in exon 3 of the PAH gene.
- Mutations R68G, R68S, R71H, S87R, P89S, I95F, and A104D were analyzed for their impact on PKU phenotypes.
- A significant finding is the proposal that mutations located between amino acid positions 71 and 94 in exon 3 are associated with mild hyperphenylalaninemia (MHP).
Conclusions:
- Exon 3 of the PAH gene harbors mutations that contribute to the spectrum of PKU disorders.
- The specific location of mutations within exon 3 influences the resulting phenotype, ranging from classical PKU to MHP.
- Mutations situated between amino acid residues 71 and 94 in the PAH enzyme's exon 3 are strongly implicated in causing mild hyperphenylalaninemia (MHP).